DCAYX | FKTQX | DCAYX / FKTQX | |
Total Expense Ratio | 0.64 | 0.48 | 133% |
Annual Report Gross Expense Ratio | 0.64 | 0.48 | 133% |
Fund Existence | 12 years | 8 years | - |
Gain YTD | -1.810 | -2.390 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 525M | 12.5B | 4% |
Annual Yield % from dividends | 3.00 | 3.90 | 77% |
Returns for 1 year | -0.39 | -1.00 | 39% |
Returns for 3 years | 8.05 | 6.43 | 125% |
Returns for 5 years | -0.06 | -3.44 | 2% |
Returns for 10 years | 15.47 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSCX | 49.21 | -0.24 | -0.49% |
BlackRock Health Sciences Opps Inv C | |||
FALIX | 54.93 | -0.63 | -1.13% |
Fidelity Advisor Large Cap I | |||
GBCCX | 14.65 | -0.17 | -1.15% |
Gabelli Dividend Growth C | |||
BUITX | 23.51 | -0.38 | -1.59% |
Buffalo Mid Cap Discovery Inst | |||
EMEAX | 12.37 | -0.23 | -1.83% |
Ashmore Emerging Markets Equity A |